Activation of human lymphocyte high affinity cyclic AMP phosphodiesterase by culture with 1-methyl-3-isobutylxanthine

W. J. Thompson, C. P. Ross, Evan M Hersh, P. M. Epstein, S. J. Strada

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

When 1-methyl-3-isobutylxanthine (MIX), a potent inhibitor of human lymphocyte cyclic AMP phosphodiesterase in vitro, was added to intact lymphocyte cultures, MIX caused an activation of this enzyme. Activation by MIX which showed an EC 50 = 0.2 mM, required 24 hr in culture, reached a maximum near 48 hr, and remained at maximum through 144 hr. The effect of MIX was to increase the maximum velocity of the 3.5-4S form but not the 5.5-6S form of the lymphocyte high affinity enzyme system. Activation required serum, occurred in calcium depleted media, and was unaffected by sodium azide, adenosine, cycloheximide, or actinomycin D. Further, the effect of MIX was not mimicked by cyclic AMP, cyclic GMP, or by a variety of cyclic nucleotide derivatives with the exception of N 6-monobutyryl- and N 6-2'0 dibutyryl cyclic AMP in the culture medium. No correlation was observed between the in vitro IC 50 value and the amount of intact cell activation with other phosphodiesterase inhibitors. Although MIX prevented the mitogenic response of lymphocytes to phytohemagglutinin (PHA), a synergistic effect to activate cyclic nucleotide phosphodiesterase was obtained when both agents were included in the culture medium. These data are discussed as an example of a novel modulation of a specific high affinity form of cyclic AMP phosphodiesterase by an apparent non-genetic regulatory mechanism.

Original languageEnglish (US)
Pages (from-to)25-36
Number of pages12
JournalJournal of Cyclic Nucleotide Research
Volume6
Issue number1
StatePublished - 1980
Externally publishedYes

Fingerprint

1-Methyl-3-isobutylxanthine
Lymphocytes
Phosphoric Diester Hydrolases
Lymphocyte Activation
Cell culture
Cyclic AMP
Chemical activation
Cyclic Nucleotides
Culture Media
Sodium Azide
Bucladesine
Enzyme Activation
Phosphodiesterase Inhibitors
Cyclic GMP
Dactinomycin
Phytohemagglutinins
Enzymes
Cycloheximide
Adenosine
Modulation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Activation of human lymphocyte high affinity cyclic AMP phosphodiesterase by culture with 1-methyl-3-isobutylxanthine. / Thompson, W. J.; Ross, C. P.; Hersh, Evan M; Epstein, P. M.; Strada, S. J.

In: Journal of Cyclic Nucleotide Research, Vol. 6, No. 1, 1980, p. 25-36.

Research output: Contribution to journalArticle

@article{599b0e6ea9c544809dfc12fc8af9694d,
title = "Activation of human lymphocyte high affinity cyclic AMP phosphodiesterase by culture with 1-methyl-3-isobutylxanthine",
abstract = "When 1-methyl-3-isobutylxanthine (MIX), a potent inhibitor of human lymphocyte cyclic AMP phosphodiesterase in vitro, was added to intact lymphocyte cultures, MIX caused an activation of this enzyme. Activation by MIX which showed an EC 50 = 0.2 mM, required 24 hr in culture, reached a maximum near 48 hr, and remained at maximum through 144 hr. The effect of MIX was to increase the maximum velocity of the 3.5-4S form but not the 5.5-6S form of the lymphocyte high affinity enzyme system. Activation required serum, occurred in calcium depleted media, and was unaffected by sodium azide, adenosine, cycloheximide, or actinomycin D. Further, the effect of MIX was not mimicked by cyclic AMP, cyclic GMP, or by a variety of cyclic nucleotide derivatives with the exception of N 6-monobutyryl- and N 6-2'0 dibutyryl cyclic AMP in the culture medium. No correlation was observed between the in vitro IC 50 value and the amount of intact cell activation with other phosphodiesterase inhibitors. Although MIX prevented the mitogenic response of lymphocytes to phytohemagglutinin (PHA), a synergistic effect to activate cyclic nucleotide phosphodiesterase was obtained when both agents were included in the culture medium. These data are discussed as an example of a novel modulation of a specific high affinity form of cyclic AMP phosphodiesterase by an apparent non-genetic regulatory mechanism.",
author = "Thompson, {W. J.} and Ross, {C. P.} and Hersh, {Evan M} and Epstein, {P. M.} and Strada, {S. J.}",
year = "1980",
language = "English (US)",
volume = "6",
pages = "25--36",
journal = "Journal of Receptor and Signal Transduction Research",
issn = "1079-9893",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Activation of human lymphocyte high affinity cyclic AMP phosphodiesterase by culture with 1-methyl-3-isobutylxanthine

AU - Thompson, W. J.

AU - Ross, C. P.

AU - Hersh, Evan M

AU - Epstein, P. M.

AU - Strada, S. J.

PY - 1980

Y1 - 1980

N2 - When 1-methyl-3-isobutylxanthine (MIX), a potent inhibitor of human lymphocyte cyclic AMP phosphodiesterase in vitro, was added to intact lymphocyte cultures, MIX caused an activation of this enzyme. Activation by MIX which showed an EC 50 = 0.2 mM, required 24 hr in culture, reached a maximum near 48 hr, and remained at maximum through 144 hr. The effect of MIX was to increase the maximum velocity of the 3.5-4S form but not the 5.5-6S form of the lymphocyte high affinity enzyme system. Activation required serum, occurred in calcium depleted media, and was unaffected by sodium azide, adenosine, cycloheximide, or actinomycin D. Further, the effect of MIX was not mimicked by cyclic AMP, cyclic GMP, or by a variety of cyclic nucleotide derivatives with the exception of N 6-monobutyryl- and N 6-2'0 dibutyryl cyclic AMP in the culture medium. No correlation was observed between the in vitro IC 50 value and the amount of intact cell activation with other phosphodiesterase inhibitors. Although MIX prevented the mitogenic response of lymphocytes to phytohemagglutinin (PHA), a synergistic effect to activate cyclic nucleotide phosphodiesterase was obtained when both agents were included in the culture medium. These data are discussed as an example of a novel modulation of a specific high affinity form of cyclic AMP phosphodiesterase by an apparent non-genetic regulatory mechanism.

AB - When 1-methyl-3-isobutylxanthine (MIX), a potent inhibitor of human lymphocyte cyclic AMP phosphodiesterase in vitro, was added to intact lymphocyte cultures, MIX caused an activation of this enzyme. Activation by MIX which showed an EC 50 = 0.2 mM, required 24 hr in culture, reached a maximum near 48 hr, and remained at maximum through 144 hr. The effect of MIX was to increase the maximum velocity of the 3.5-4S form but not the 5.5-6S form of the lymphocyte high affinity enzyme system. Activation required serum, occurred in calcium depleted media, and was unaffected by sodium azide, adenosine, cycloheximide, or actinomycin D. Further, the effect of MIX was not mimicked by cyclic AMP, cyclic GMP, or by a variety of cyclic nucleotide derivatives with the exception of N 6-monobutyryl- and N 6-2'0 dibutyryl cyclic AMP in the culture medium. No correlation was observed between the in vitro IC 50 value and the amount of intact cell activation with other phosphodiesterase inhibitors. Although MIX prevented the mitogenic response of lymphocytes to phytohemagglutinin (PHA), a synergistic effect to activate cyclic nucleotide phosphodiesterase was obtained when both agents were included in the culture medium. These data are discussed as an example of a novel modulation of a specific high affinity form of cyclic AMP phosphodiesterase by an apparent non-genetic regulatory mechanism.

UR - http://www.scopus.com/inward/record.url?scp=0018834121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018834121&partnerID=8YFLogxK

M3 - Article

C2 - 6155390

AN - SCOPUS:0018834121

VL - 6

SP - 25

EP - 36

JO - Journal of Receptor and Signal Transduction Research

JF - Journal of Receptor and Signal Transduction Research

SN - 1079-9893

IS - 1

ER -